Combined Saxagliptin and Dapagliflozin Reduce Blood Glucose Levels in T2DM Patients

Article Information

DOI 
http://dx.doi.org/10.1177/155989771432004
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Nicola Parry
  1. Julio Rosenstock, MD
    1. Dallas Diabetes and Endocrine Center and University of Texas Southwestern Medical School, Dallas, Texas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015321
Jun 20151611
Jul 2015711
Aug 2015100
Sep 2015900
Oct 2015232
Total4475

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Combined Saxagliptin and Dapagliflozin Reduce Blood Glucose Levels in T2DM Patients
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Diabetes Mellitus
Hyperglycemia/Hypoglycemia
Diabetes & Endocrinology Clinical Trials
Endocrinology
Diabetes & Metabolic Syndrome
Diabetes Mellitus
Hyperglycemia/Hypoglycemia
Diabetes & Endocrinology Clinical Trials